Cell And Gene Therapies Are Altering Patient Expectations, Says CGT Catapult CEO
Patients Will Expect Their Condition To Be Taken Away, Rather Than Treated
Matthew Durdy took over as CGT Catapult CEO as the COVID-19 pandemic began in early 2020 • Source: Shutterstock 
